Zhu K - Search Results

1

Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes.

Liu J, Yang S, Cao B, Zhou G, Zhang F, Wang Y, Wang R, Zhu L, Meng Y, Hu C, Liang H, Lin X, Zhu K, Chen G, Luo KQ, Di L, Zhao Q. Liu J, et al. Among authors: zhu k, zhu l. J Hematol Oncol. 2021 Jan 29;14(1):21. doi: 10.1186/s13045-020-01024-8. J Hematol Oncol. 2021. PMID: 33514401 Free PMC article.

2

Development of mesothelin-specific CAR NK-92 cells for the treatment of gastric cancer.

Cao B, Liu M, Huang J, Zhou J, Li J, Lian H, Huang W, Guo Y, Yang S, Lin L, Cai M, Zhi C, Wu J, Liang L, Hu Y, Hu H, He J, Liang B, Zhao Q, Zhu K. Cao B, et al. Among authors: zhu k. Int J Biol Sci. 2021 Sep 3;17(14):3850-3861. doi: 10.7150/ijbs.64630. eCollection 2021. Int J Biol Sci. 2021. PMID: 34671203 Free PMC article.

3

CAR NK-92 cells targeting DLL3 kill effectively small cell lung cancer cells in vitro and in vivo.

Liu M, Huang W, Guo Y, Zhou Y, Zhi C, Chen J, Li J, He J, Lian H, Zhou J, Ye X, Hu Y, Hu H, Liu Z, Huang J, Lin L, Cai M, Wang X, Huang J, Zhang Z, Zhu K, Zhao Q, Cao B. Liu M, et al. Among authors: zhu k. J Leukoc Biol. 2022 Oct;112(4):901-911. doi: 10.1002/JLB.5MA0122-467R. Epub 2022 Jan 28. J Leukoc Biol. 2022. PMID: 35088475

4

Transarterial Chemoembolization Combined With Lenvatinib Plus PD-1 Inhibitor for Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study.

Cai M, Huang W, Huang J, Shi W, Guo Y, Liang L, Zhou J, Lin L, Cao B, Chen Y, Zhou J, Zhu K. Cai M, et al. Among authors: zhu k. Front Immunol. 2022 Mar 1;13:848387. doi: 10.3389/fimmu.2022.848387. eCollection 2022. Front Immunol. 2022. PMID: 35300325 Free PMC article.

5

Remodelling of tumour microenvironment by microwave ablation potentiates immunotherapy of AXL-specific CAR T cells against non-small cell lung cancer.

Cao B, Liu M, Wang L, Zhu K, Cai M, Chen X, Feng Y, Yang S, Fu S, Zhi C, Ye X, Zhang J, Zhang Z, Yang X, Zhao M, Wu Q, Xu L, Yang L, Lian H, Zhao Q, Zhang Z. Cao B, et al. Among authors: zhu k. Nat Commun. 2022 Oct 19;13(1):6203. doi: 10.1038/s41467-022-33968-5. Nat Commun. 2022. PMID: 36261437 Free PMC article.

6

Tyrosine-kinase inhibitor combined with iodine-125 seed brachytherapy for hepatocellular carcinoma refractory to transarterial chemoembolization: a propensity-matched study.

Guo Y, Wu J, Liang L, Zhu K, Zhou J, Lin L, Chen Y, Cao B, He M, Lian H, Huang W, Cai M. Guo Y, et al. Among authors: zhu k. Cancer Imaging. 2023 Sep 25;23(1):91. doi: 10.1186/s40644-023-00604-4. Cancer Imaging. 2023. PMID: 37749616 Free PMC article.

7

Lenvatinib, sintilimab plus transarterial chemoembolization for advanced stage hepatocellular carcinoma: A phase II study.

Cai M, Huang W, Liang W, Guo Y, Liang L, Lin L, Xie L, Zhou J, Chen Y, Cao B, Wu J, Zhu K. Cai M, et al. Among authors: zhu k. Liver Int. 2024 Apr;44(4):920-930. doi: 10.1111/liv.15831. Epub 2024 Jan 30. Liver Int. 2024. PMID: 38291865 Clinical Trial.

8

Efficacy and Safety of CalliSpheres^® Drug-Eluting Beads Transarterial Chemoembolization in Barcelona Clinic Liver Cancer Stage C Patients.

Liu Y, Huang W, He M, Lian H, Guo Y, Huang J, Zhou J, Zhu K. Liu Y, et al. Among authors: zhu k. Oncol Res. 2019 May 7;27(5):565-573. doi: 10.3727/096504018X15313896322888. Epub 2018 Jul 13. Oncol Res. 2019. PMID: 30005719 Free PMC article.

9

Mannose-Derived Carbon Dots Amplify Microwave Ablation-Induced Antitumor Immune Responses by Capturing and Transferring "Danger Signals" to Dendritic Cells.

Zhou Q, Gong N, Zhang D, Li J, Han X, Dou J, Huang J, Zhu K, Liang P, Liang XJ, Yu J. Zhou Q, et al. Among authors: zhu k. ACS Nano. 2021 Feb 23;15(2):2920-2932. doi: 10.1021/acsnano.0c09120. Epub 2021 Feb 1. ACS Nano. 2021. PMID: 33523631

10

Dual-Sensitive PEG-Sheddable Nanodrug Hierarchically Incorporating PD-L1 Antibody and Zinc Phthalocyanine for Improved Immuno-Photodynamic Therapy.

Su Z, Xiao Z, Huang J, Wang Y, An Y, Xiao H, Peng Y, Pang P, Han S, Zhu K, Shuai X. Su Z, et al. Among authors: zhu k. ACS Appl Mater Interfaces. 2021 Mar 24;13(11):12845-12856. doi: 10.1021/acsami.0c20422. Epub 2021 Mar 12. ACS Appl Mater Interfaces. 2021. PMID: 33709684

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,098 results

Search Page

Filters